Literature DB >> 18007483

Electron-induced (EI) mass fragmentation is directed by intra-molecular H-bonding in two isomeric benzodipyran systems.

Cornelis J Van der Schyf1, Stéphane Mabic.   

Abstract

The striking differences observed in the electron-induced (EI) mass fragmentation pathways of two isomeric benzodipyrans are attributable to hydrogen bonding in these molecules. In the "angular" isomer, 6-butyryl-5-hydroxy-2,2,8,8-tetramethyl-3,4,9,10-tetra-hydro-2H,8H-benzo[1,2-b:3,4-b(1)]dipyran (2), H-bonding occurs between the aromatic OH group and the alpha carbonyl moiety contained in the ortho-phenone group, whereas in the"linear" isomer, 10-butyryl-5-hydroxy-2,2,8,8-tetramethyl-3,4,6,7-tetrahydro-2H,8H-benzo-[1,2-b:5,4-b(1)]dipyran (3), the aromatic OH group is para to the phenone moiety, effectively precluding any H-bonding. Semi-empirical molecular orbital calculations (AM1) were used to compare predicted sites of ionization with associated fragmentation patterns. In both molecules, the highest occupied molecular orbital (HOMO) was located predominantly on the aromatic moiety. Similarly, in the radical cation species of both compounds, maximum spin density was located over the aromatic rings. Neither the HOMO nor the spin density maps provided a rational explanation for the differences in fragmentation patterns of the two benzodipyran isomers. The H-bonding favors EI alpha aromatic ring C-O bond cleavage in the"angular" benzodipyran and in 5,7-dihydroxy-2,2-dimethyl-8-butyryl chroman (1), a related monochroman also containing a hydrogen proximal to the aromatic ring C-O bond. In contrast,fragmentation of the "linear" benzodipyran followed a different route, which was exhibited by its base peak resulting from the loss of a propyl group from the butyryl side-chain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 18007483      PMCID: PMC6147304          DOI: 10.3390/91000830

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  12 in total

1.  Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines.

Authors:  R Hiessböck; C Wolf; E Richter; M Hitzler; P Chiba; M Kratzel; G Ecker
Journal:  J Med Chem       Date:  1999-06-03       Impact factor: 7.446

2.  Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety.

Authors:  T Ueno; H Takahashi; M Oda; M Mizunuma; A Yokoyama; Y Goto; Y Mizushina; K Sakaguchi; H Hayashi
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

3.  Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity.

Authors:  G C Rovnyak; S Z Ahmed; C Z Ding; S Dzwonczyk; F N Ferrara; W G Humphreys; G J Grover; D Santafianos; K S Atwal; A J Baird; L G McLaughlin; D E Normandin; P G Sleph; S C Traeger
Journal:  J Med Chem       Date:  1997-01-03       Impact factor: 7.446

Review 4.  Determination of tea catechins.

Authors:  J J Dalluge; B C Nelson
Journal:  J Chromatogr A       Date:  2000-06-09       Impact factor: 4.759

5.  Myrsinoic acids B, C and F, anti-inflammatory compounds from Myrsine seguinii.

Authors:  Mitsuru Hirota; Shintaro Miyazaki; Tomomi Minakuchi; Tomoko Takagi; Hisao Shibata
Journal:  Biosci Biotechnol Biochem       Date:  2002-03       Impact factor: 2.043

6.  3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].

Authors:  C Comoy; C Marot; T Podona; M L Baudin; L Morin-Allory; G Guillaumet; B Pfeiffer; D H Caignard; P Renard; M C Rettori; G Adam; B Guardiola-Lemaitre
Journal:  J Med Chem       Date:  1996-10-11       Impact factor: 7.446

7.  Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.

Authors:  D M Benbrook; M M Madler; L W Spruce; P J Birckbichler; E C Nelson; S Subramanian; G M Weerasekare; J B Gale; M K Patterson; B Wang; W Wang; S Lu; T C Rowland; P DiSivestro; C Lindamood; D L Hill; K D Berlin
Journal:  J Med Chem       Date:  1997-10-24       Impact factor: 7.446

8.  Benzodipyran derivatives with antiallergic activity.

Authors:  J R Bantick; H Cairns; A Chambers; R Hazard; J King; T B Lee
Journal:  J Med Chem       Date:  1976-06       Impact factor: 7.446

9.  Synthesis and antimicrobial activity of a series of caespitin derivatives.

Authors:  C J Van der Schyf; T G Dekker; T G Fourie; F O Snyckers
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 10.  Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life.

Authors:  K D Setchell; L Zimmer-Nechemias; J Cai; J E Heubi
Journal:  Am J Clin Nutr       Date:  1998-12       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.